Docusign, Inc. 2027 Q1 Financial Report: Detailed Analysis for Investors
Key Points from the Q1 2027 Report
- Quarterly Period: Ended April 30, 2026
- Filing Type: Form 10-Q (Quarterly Report)
- Stock Information:
- Common Stock, par value \$0.0001 per share
- Trading Symbol: DOCU
- Exchange: The Nasdaq Global Select Market
- Shares Outstanding as of May 29, 2026: 190,944,608
- Reporting Status: The company has filed all required reports and has been subject to filing requirements for the past 90 days.
- Filer Status: Large Accelerated Filer
- Shell Company Status: Not a shell company
Financial Performance Overview
- Net Income:
- Q1 2027 (ended April 30, 2026): \$78.2 million
- Q1 2026 (ended April 30, 2025): \$72.1 million
- Net Income per Share (EPS):
- Basic EPS Q1 2027: \$0.40
- Diluted EPS Q1 2027: \$0.40
- Basic EPS Q1 2026: \$0.35
- Diluted EPS Q1 2026: \$0.34
- Weighted-Average Shares Outstanding, Basic: 195,489,000 (Q1 2027)
- Weighted-Average Shares Outstanding, Diluted: 196,105,000 (Q1 2027)
- Stockholders’ Equity: \$1.82 billion as of April 30, 2026
Stock Activities and Shareholder Movements
- Share Repurchases:
- Repurchased approximately 6.8 million shares during Q1 2027, reducing shares outstanding and potentially providing price support.
- Cash used for share repurchases in Q1 2027: \$317.5 million
- Employee Stock Activities:
- Employee stock purchase plan resulted in issuance of 555,000 shares, with proceeds of \$22.8 million.
- Settlement of restricted stock units: 2.4 million shares issued.
- Exercise of stock options: 3,000 shares issued, proceeds \$53,000.
- Tax withholding on restricted stock and ESPP: 892,000 shares withheld.
Balance Sheet Highlights
- Cash and Marketable Securities: The company continues to have significant liquidity, with robust cash balances and investments in marketable securities.
- No Preferred Stock Outstanding: 10 million shares authorized, but none issued or outstanding.
- Common Stock Authorized: 500 million shares authorized; 193,057,000 issued and outstanding as of April 30, 2026.
Cash Flow Insights
- Cash Flows from Operations: Strong positive cash flow from operations (exact figure not stated, but implied from positive net income and equity movements).
- Investing Activities:
- Purchases of marketable securities: \$97.4 million
- Maturities of securities provided \$93.0 million in cash
- Net cash used in investing activities: \$24.9 million
- Financing Activities:
- Repurchases of common stock: \$317.5 million outflow
- Tax withholding for equity compensation: \$62.8 million outflow
- Proceeds from stock option exercises and ESPP: combined over \$44 million
Risks and Forward-Looking Statements
- Forward-Looking Risks: The company highlighted substantial risks and uncertainties including:
- Ability to meet industry standards and regulatory requirements
- Intellectual property protection
- Litigation risks
- Executive management transitions
- General economic and market conditions, including geopolitical and trade policy changes
- Maintaining effective internal controls
- Disclaimer on Forward-Looking Statements: Docusign cautions investors not to rely unduly on forward-looking statements, as actual results could differ materially due to risks and uncertainties.
Potentially Price-Sensitive Developments
- Strong Earnings Growth: The company delivered notable year-over-year growth in net income and EPS, reflecting positive operational leverage and cost control.
- Significant Share Buybacks: The aggressive share repurchase program, with \$317.5 million spent in Q1 alone, is likely to be seen favorably by the market as it demonstrates management’s confidence in the business and provides direct support to the share price.
- Healthy Balance Sheet: The company’s sizable stockholders’ equity and continued cash generation position it well for future investments, shareholder returns, or strategic flexibility.
- Shareholder Dilution Impact: While share buybacks are supportive, ongoing employee stock issuance and restricted stock settlements do create modest dilution, something investors should balance against repurchases.
Conclusion
Docusign, Inc. has reported a strong Q1 2027 with increased profitability, significant cash returns to shareholders via buybacks, and ongoing investments in talent and technology. The company continues to invest in its product suite and maintain a solid financial position, but also acknowledges competitive pressures and macroeconomic uncertainties. The aggressive share repurchase and robust earnings growth are likely to be viewed positively by the market, potentially boosting investor confidence and share value in the near term.
Disclaimer: This article is a summary and analysis of Docusign, Inc.’s Q1 2027 financial report, intended for informational purposes only. It does not constitute investment advice. Investors should review the full official filings and consider their own risk tolerance before making any investment decisions. Forward-looking statements in the company’s filings are subject to risks and actual results may differ materially.
